Eurofins Scientific: Director/PDMR Shareholding
For best results when printing this announcement, please click on link below: Eurofins Scientific: Director/PDMR Shareholding Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM 1. Details of the person discharging managerial responsibilities/person closely associated a) Name Analytical Bioventures S.C.A (RCS B89265) 23, Val Fleuri, L-1526 Luxembourg 2. Reason for the notification a) Position / status Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin b) Initial notification / amendment Initial 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Eurofins Scientific S.E. b) LEI 529900JEHFM47DYY3S57 4. Details of the transaction(s) section to be repeated for (i) each type of instrument;
Story updates
PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM 1.
A (RCS B89265) 23, Val Fleuri, L-1526 Luxembourg 2. A. , CEO Dr. Gilles Martin b) Initial notification / amendment Initial 3.
E. b) LEI 529900JEHFM47DYY3S57 4. 5038 e) Date of the transaction 2026-09-21 f) Place of the transaction XPAR NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM 1. A (RCS B89265) 23, Val Fleuri, L-1526 Luxembourg 2.
A. , CEO Dr. Gilles Martin b) Initial notification / amendment Initial 3. E.
b) LEI 529900JEHFM47DYY3S57 4. 4553 e) Date of the transaction 2026-09-22 f) Place of the transaction XPAR NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM 1. A (RCS B89265) 23, Val Fleuri, L-1526 Luxembourg 2. A.
, CEO Dr. Gilles Martin b) Initial notification / amendment Initial 3. E. b) LEI 529900JEHFM47DYY3S57 4.
8182 e) Date of the transaction 2026-09-23 f) Place of the transaction XPAR For more information, please visit About Eurofins — the global leader in bio-analysis Eurofins is Testing for Life. With over 65,000 staff across a network of more than 950 laboratories in over 1,000 companies in 57 countries, Eurofins offers a portfolio of over 200,000 analytical methods. E. shares are listed on Euronext Paris Stock Exchange.
com: Investor Relations Eurofins Scientific SE Phone: +32 2 766 1620